WordNet

used especially of solids or solutions; incapable of blending into a stable homogeneous mixture
incapable of being used with or connected to other devices or components without modification
not compatible; "incompatible personalities"; "incompatible colors"
either of two bean-shaped excretory organs that filter wastes (especially urea) from the blood and excrete them and water in urine; "urine passes out of the kidney through ureters to the bladder"

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 移植腎機能障害をきたす患者の評価および診断 evaluation and diagnosis of the patient with renal allograft dysfunction
2. 腎移植におけるHLAとABOの感作および脱感作 hla and abo sensitization and desensitization in renal transplantation
3. 腎同種移植片のC4d染色および抗体媒介性拒絶反応の治療 c4d staining in renal allografts and treatment of antibody mediated rejection
4. 成人腎移植レシピエントの診療の概要 overview of care of the adult kidney transplant recipient
5. 成人の腎移植における免疫抑制誘導療法 induction immunosuppressive therapy in renal transplantation in adults

Histologic Phenotype on 1-Year Posttransplantation Biopsy and Allograft Survival in HLA-Incompatible Kidney Transplants.

Sharif A1, Kraus ES, Zachary AA, Lonze BE, Nazarian SM, Segev DL, Alachkar N, Arend LJ, Bagnasco SM, Racusen LC, Montgomery RA.Author information 11 Renal Institute of Birmingham, Queen Elizabeth Hospital, Birmingham, United Kingdom. 2 Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, MD. 3 Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, MD. 4 Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD. 5 Address correspondence to: Robert Montgomery, Ph.D., Department of Surgery, Johns Hopkins Medical Institutions, 720 Rutland Avenue, Ross Research 765, Baltimore, MD 21205.AbstractBACKGROUND: The correlation between histopathologic phenotypes and allograft outcomes among patients desensitized for donor-specific antibody (HLA-incompatible) is unknown.
Transplantation.Transplantation.2014 Mar 15;97(5):541-7. doi: 10.1097/01.TP.0000442513.27641.7e.
BACKGROUND: The correlation between histopathologic phenotypes and allograft outcomes among patients desensitized for donor-specific antibody (HLA-incompatible) is unknown.METHODS: We analyzed 1-year biopsies from desensitized recipients transplanted between 1999 and 2010 and estimated graft surviva
PMID 24521779

Time Course of Pathologic Changes in Kidney Allografts of Positive Crossmatch HLA-Incompatible Transplant Recipients.

Bagnasco SM1, Zachary AA, Racusen LC, Arend LJ, Carter-Monroe N, Alachkar N, Nazarian SM, Lonze BE, Montgomery RA, Kraus ES.Author information 11 Department of Pathology, Johns Hopkins University, Baltimore, MD. 2 Department of Medicine, Johns Hopkins University, Baltimore, MD. 3 Department of Surgery, Johns Hopkins University, Baltimore, MD. 4 Address correspondence to: Serena M. Bagnasco, M.D., Department of Pathology, Johns Hopkins University, Ross 632, 720 Rutland Avenue, Baltimore, MD 21205.AbstractBACKGROUND: Recipients of incompatible allografts are at increased risk of graft loss. We hypothesized that analysis of sequential biopsies from these grafts could define progression of graft lesions and identify features predictive of progression.
Transplantation.Transplantation.2014 Feb 27;97(4):440-5. doi: 10.1097/01.TP.0000437177.40551.f4.
BACKGROUND: Recipients of incompatible allografts are at increased risk of graft loss. We hypothesized that analysis of sequential biopsies from these grafts could define progression of graft lesions and identify features predictive of progression.METHODS: We studied the time course of histologic in
PMID 24531821

Late antibody-mediated rejection after ABO-incompatible kidney transplantation during Gram-negative sepsis.

de Weerd A1, Vonk A, van der Hoek H, van Groningen M, Weimar W, Betjes M, van Agteren M.Author information 1Erasmus Medical Center Rotterdam, Department of Nephrology, Room D-411, P,O, Box 2040, 3000 CA Rotterdam, The Netherlands. a.deweerd@erasmusmc.nl.AbstractBACKGROUND: The major challenge in ABO-incompatible transplantation is to minimize antibody-mediated rejection. Effective reduction of the anti-ABO blood group antibodies at the time of transplantation has made ABO-incompatible kidney transplantation a growing practice in our hospital and in centers worldwide. ABO antibodies result from contact with A- and B-like antigens in the intestines via nutrients and bacteria. We demonstrate a patient with fulminant antibody-mediated rejection late after ABO-incompatible kidney transplantation, whose anti-A antibody titers rose dramatically following Serratia marcescens sepsis.
BMC nephrology.BMC Nephrol.2014 Feb 12;15(1):31. doi: 10.1186/1471-2369-15-31.
BACKGROUND: The major challenge in ABO-incompatible transplantation is to minimize antibody-mediated rejection. Effective reduction of the anti-ABO blood group antibodies at the time of transplantation has made ABO-incompatible kidney transplantation a growing practice in our hospital and in centers
PMID 24517251

リンク元	「血液型不適合腎移植」
拡張検索	「blood type incompatible kidney transplantation」
関連記事	「transplantation」「incompatible」「kidney」